Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer
Clinical trial NCT02619669 · WITHDRAWN
Trial details
- NCT number
- NCT02619669
- Sponsor
- Gary Schwartz
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-20
- Primary completion
- 2019-06-14
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.